The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
about
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The potential overlapping popu ...... idelines in England and Wales.
@en
type
label
The potential overlapping popu ...... idelines in England and Wales.
@en
prefLabel
The potential overlapping popu ...... idelines in England and Wales.
@en
P2093
P2860
P50
P356
P6366
P1154
2-s2.0-85021107755
P1433
P1476
The potential overlapping popu ...... idelines in England and Wales.
@en
P2093
Anisur Rahman
Bridget Griffiths
British Isles Lupus Assessment Group Biologics Register
Chee-Seng Yee
Christopher J Edwards
David A Isenberg
David Jayne
David P D'Cruz
Emily Sutton
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEX044
P5530
P577
2017-06-01T00:00:00Z
P6179
1083934312
P6366
2596910731